SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001179110-18-002730
Filing Date
2018-02-23
Accepted
2018-02-23 16:38:53
Documents
2
Period of Report
2017-12-14

Document Format Files

Seq Description Document Type Size
1 FORM 3 - edgar.html 3  
1 FORM 3 - edgar.xml 3 1649
2 ex24berkowitz.txt EX-24 3906
  Complete submission text file 0001179110-18-002730.txt   7021
Mailing Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108
Business Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108 734-887-3903
Esperion Therapeutics, Inc. (Issuer) CIK: 0001434868 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O WALGREENS BOOTS ALLIANCE DEVELOPMENT UNTERMATTWEG 8 BERN V8 CH 3027
Business Address
Berkowitz Jeffrey (Reporting) CIK: 0001596932 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35986 | Film No.: 18637108